All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| 74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
| PETX / Aratana Therapeutics, Inc.
|
|
|
|
|
|
|
|
| INTRA CELLULAR THERAPIES INC
/ (04611X101) |
|
|
|
|
|
|
|
| US64052L1061 / Neos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
| ZSAN / Zosano Pharma Corp
|
|
|
|
|
|
|
|
| / Immunomedics, Inc.
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| US60877T1007 / Momenta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
| PDSB / PDS Biotechnology Corporation
|
|
|
|
|
|
|
|
| AXGN / Axogen, Inc.
|
|
|
|
|
|
|
|
| NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
| SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
| ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
| MDGN / Medgenics, Inc.
|
|
|
|
|
|
|
|
| XOMA / XOMA Royalty Corporation
|
|
|
|
|
|
|
|
| ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
| CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
| CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| 0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
| SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
| EGRX / Eagle Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TBPH / Theravance Biopharma, Inc.
|
|
|
|
|
|
|
|
| ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
| NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
| OCUL / Ocular Therapeutix, Inc.
|
|
|
|
|
|
|
|
| BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CARA / Cara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
| HROW / Harrow, Inc.
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
